Literature DB >> 14997941

Selectivity and types of cell death in the neuronal ceroid lipofuscinoses.

Hannah M Mitchison1, Ming J Lim, Jonathan D Cooper.   

Abstract

Cloning of the individual genes that are mutated in the neuronal ceroid lipofuscinoses (NCLs), or Batten disease, has opened up new avenues of research into the pathogenesis of these fatal autosomal recessive storage disorders. Genetically accurate mouse models have now been generated for each major form of the disorder, together with several variant forms. Ongoing analysis of these mice is revealing significant new data about the staging and progression of disease phenotypes. Combined with data from human autopsy tissues and large animal models, it is now clear that neurodegeneration is initially selective in the NCL CNS, targeting specific regions and particular cell populations. There is also evidence of selective glial activation that appears to precede obvious neurodegeneration, becoming more widespread with disease progression. Currently, there is debate over the mechanisms of cell death that operate in each form of NCL, with evidence of both apoptosis and autophagy. It is likely that these mechanisms may encompass a spectrum of cell death events, depending upon the specific context of each neuronal population. Taken together, these data have significant clinical implications for the development and targeting of appropriate therapeutic strategies, and for providing the landmarks to judge their efficacy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997941     DOI: 10.1111/j.1750-3639.2004.tb00502.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  29 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis.

Authors:  Marie S Roberts; Shannon L Macauley; Andrew M Wong; Denis Yilmas; Sarah Hohm; Jonathan D Cooper; Mark S Sands
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

3.  Genetic modulation of apoptotic pathways fails to alter disease course in tripeptidyl-peptidase 1 deficient mice.

Authors:  Kwi-Hye Kim; David E Sleat; Ora Bernard; Peter Lobel
Journal:  Neurosci Lett       Date:  2009-02-04       Impact factor: 3.046

4.  A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.

Authors:  Naser Gilani; Ehsan Razmara; Mehmet Ozaslan; Ihsan Kareem Abdulzahra; Saeid Arzhang; Ali Reza Tavasoli; Masoud Garshasbi
Journal:  Acta Neurol Belg       Date:  2021-03-30       Impact factor: 2.396

5.  Autophagy in neuroprotection and neurodegeneration: A question of balance.

Authors:  Salvatore J Cherra; Charleen T Chu
Journal:  Future Neurol       Date:  2008-05

6.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

7.  Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Authors:  Colleen S Stein; Paul H Yancey; Inês Martins; Rita D Sigmund; John B Stokes; Beverly L Davidson
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

8.  A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.

Authors:  Nesrin Besbas; Markus Draaken; Michael Ludwig; Ozgur Deren; Diclehan Orhan; Yelda Bilginer; Fatih Ozaltin
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

9.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 10.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.